It has been two and a half years since the emergence of the SARS-CoV-2 virus and the COVID-19 outbreak. Despite the success of safe and efficacious vaccines for COVID-19, people still fall ill due to viral infection and the ensuing complications. With the continual emergence of SARS-CoV-2 variants of interest, the threat is far from over. In this webinar, Lianghui (Lucy) Zhang and Michael Cobas Meyer will discuss strategies employed by scientists to develop effective therapies for COVID-19.
Topics to be covered
Lianghui (Lucy) Zhang, MD, PhD
Department of Pharmacology & Regeneration
University of Illinois at Chicago
Michael Cobas Meyer, MD
Neuroscience Pain Early and Late Phase Development and Lilly Research Laboratories COVID-19 Therapies
Eli Lilly and Company